This inventor holds 1 USPTO granted patent. Top assignee: Shanghai Hyamab Biotech Co., Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Haohan Liu - Innovator in Antibody Development
Introduction
Haohan Liu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic use. His work focuses on innovative solutions for treating cancers and autoimmune diseases.
Latest Patents
Haohan Liu holds a patent for a 4-1BB antibody and its preparation method and use. This invention provides a 4-1BB antibody that exhibits high affinity to the 4-1BB protein. It effectively activates the downstream signaling of 4-1BB and significantly increases the expression of IFN-γ and IL-2 in human mixed lymphocytes or T lymphocytes. This advancement has potential applications in treating various cancers and autoimmune diseases.
Career Highlights
Liu is associated with Shanghai Hyamab Biotech Co., Ltd., where he continues to push the boundaries of antibody research. His work is characterized by a commitment to developing effective therapeutic agents that can improve patient outcomes.
Collaborations
Haohan Liu collaborates with notable colleagues, including Heng Pan and Yingying Gao. Their combined expertise enhances the research and development efforts at their company.
Conclusion
Haohan Liu's innovative work in antibody development represents a significant advancement in biotechnology. His contributions have the potential to impact the treatment of serious health conditions, showcasing the importance of research and innovation in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile